It has been authorized in more than 70 countries
Although some countries have suspended the use of AstraZeneca’s coronavirus vaccine for safety reasons, Thailand started a nationwide distribution plan on Tuesday, and Prime Minister Prayuth Chan-ocha received the first injection. .
Thailand is one of several countries that continue to use the AstraZeneca vaccine, including Australia and India, as experts investigated reports of fatal cerebral hemorrhages and blood clots among the few people who received the vaccine. Millions of people around the world have been vaccinated with the AstraZeneca vaccine. Scientists say that there is no evidence that it causes blood clots, and it may occur for various reasons.
In recent days, more than a dozen countries, mainly in Europe, have stopped vaccines against AstraZeneca, which makes people worry that the vaccine will be discontinued at a critical moment. In Asia, Indonesia also stated yesterday that it will not start distributing AstraZeneca vaccines until its safety is confirmed.
AstraZeneca’s vaccine has been licensed in more than 70 countries and is considered the key to fighting the virus in the underdeveloped world because it is cheaper and easier to store than other vaccines.
Despite the suspension, other countries agree that there is insufficient evidence to justify the suspension. The Australian Drug Regulatory Agency said in a statement on Tuesday that it has not received any reports of blood clots among people receiving AstraZeneca vaccination. Health Minister Greg Hunt also stated that the government supports the continued use of injections.
AstraZeneca is at the core of Australia’s vaccination campaign, and most of the 53.8 million doses of vaccine obtained by the government are produced in Australia.
An Indian official known as Covishield who produces the AstraZeneca vaccine locally in India said that there are no immediate issues of concern. They are reviewing data on the adverse effects of the AstraZeneca vaccine and another injection used (a household vaccine called Covaxin).